Associate Director Commercial Effectiveness

Job description

ジェンマブは革新的な抗体医薬の開発に注力し、患者さんの生活を改善することに力を尽くしています。 私たちは、extra[not]ordinary® な未来を共に築くことを使命とし、革新的な抗体製品の開発や人々を感動させる抗体医薬品で、がんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え、治療の未来を切り拓いています。 ジェンマブは思いやりがあり、率直で、患者さんに貢献したいという強い思いを持った人たちがともに働き、科学に基づく変化をもたらします。大胆さと高潔性を持って行動し、新しい未来をつくることを目指すこと が、この使命を果たすために不可欠だと信じています。 私たちは大きな志を掲げ、楽しく、そして思いやりの心を忘れずに、日々意義のある仕事に取り組んでいます。私たちは、個々のユニークな貢献を受け入れ、それらを原動力として、患者、ケアパートナー、ご家族、そして社員のニーズを満たす革新的なソリューションを生み出し、育み、維持するグローバルな企業文化の構築に努めています。 私たちの想いに共鳴し、自分らしく活躍できそうだと感じたら、ぜひ一緒に働きましょう。 Position Summary The Associate Director, Commercial Effectiveness leads the integrated capabilities that convert commercial strategy, market intelligence, and data into measurable business performance for Genmab KK (Japan). Reporting to the Head of Commercial Excellence, the role provides strategic and operational leadership across Sales Force Effectiveness (SFE), Business Intelligence (BI), Competitive Intelligence (CI), and Data Analytics. The position ensures that these four capabilities operate as one connected decision-support and execution engine. It partners closely with Sales, Marketing, Medical, Finance, Market Access, Human Resources, DDAI/IT, global functions, and external partners to strengthen launch readiness, brand execution, customer engagement, field performance, and long-term commercial growth. Functional Scope SFE: field-force design and deployment, segmentation and targeting, territory and call planning, CRM enablement, KPIs, incentives, performance management, and operating standards. BAI: market, customer, brand, and business intelligence, including market research, performance reporting, forecasting, and decision support. Structured monitoring and interpretation of competitor activity, treatment landscapes, congress developments, and emerging threats or opportunities. Primary Roles & Responsibilities Commercial Effectiveness Strategy and Leadership Translate company, portfolio, brand, and launch strategies into an integrated commercial effectiveness agenda with clear priorities, governance, roadmaps, and measurable outcomes. Advise the Head of Commercial Excellence and commercial leadership on performance opportunities, risks, resource choices, and corrective actions using market evidence, customer insight, field execution, and financial impact. Align SFE, BAI around common definitions, assumptions, KPIs, and decision processes across brands and functions. Lead strategic initiatives that strengthen Japan's commercial model, including launch excellence, CRM evolution, advanced analytics, automation, and AI-supported decision-making. Sales Force Effectiveness (SFE) Lead field-force effectiveness strategy, including segmentation, targeting, territory design and alignment, account and call planning, target allocation, and field execution standards. Establish sales, brand, activity, and customer-engagement KPIs; monitor performance and recommend timely actions to Sales and Marketing leadership. Oversee the design, governance, calculation, communication, and evaluation of sales incentive and recognition programs in partnership with Sales, HR, Finance, and relevant governance bodies. Own the business direction for field CRM and SFE tools, including Veeva-related capabilities, reporting requirements, adoption, training, operational controls, and continuous improvement. Standardize and document critical SFE processes to improve quality, continuity, scalability, audit readiness, and automation or outsourcing opportunities. Business Analytics and Intelligence (B A I) Set the BI agenda for Japan and ensure timely, accurate, and decision-relevant reporting on sales, market share, customer engagement, field activity, launch progress, and brand performance. Lead management dashboards and recurring performance reviews, clearly interpreting performance drivers, implications, and recommended actions. Partner with Marketing, Finance, Sales, Medical, and global teams to develop key assumptions, market assessments, scenarios, forecasts, and business cases. Sponsor primary and secondary research addressing critical business questions, including patient journey, treatment dynamics, demand, brand tracking, launch baselines, and customer needs. Establish a systematic CI capability covering competitor strategies, clinical and regulatory developments, treatment landscapes, congress activity, market access dynamics, and emerging disruptions. Validate, synthesize, and translate intelligence into implications for Genmab's portfolio, launch plans, brand strategy, forecasts, and field execution. Partner with global BI/CI counterparts so Japan-specific insights are incorporated into regional and global perspectives and relevant global learning is applied locally. Maintain compliant processes for collecting, sharing, escalating, and retaining competitive intelligence, including appropriate vendor governance. Cross-Functional Partnership, People, and Governance Serve as a trusted thought partner to Sales, Marketing, Medical, Finance, Market Access, DDAI/IT, HR, and global functions, constructively challenging assumptions and aligning stakeholders around evidence-based choices. Support launch readiness and post-launch optimization by establishing market baselines, performance measures, customer and competitor insight, field-force readiness, and rapid feedback loops. Lead, coach, and develop a high-performing team across SFE, BI, CI, and Data Analytics; clarify accountabilities and build succession and capability plans. Prioritize demand, allocate internal and external resources, manage budgets and vendors, and maintain transparent delivery commitments. Ensure activities comply with applicable laws, industry codes, company policies, privacy and security requirements, promotional standards, and audit expectations. Leadership Competencies Strategic orientation — connects portfolio and brand priorities to practical capability and execution choices. Commercial and analytical judgment — balances evidence, business context, risk, and speed to make sound recommendations. Enterprise collaboration — creates alignment across functions and levels without relying solely on formal authority. Change leadership — turns new processes, tools, data, and ways of working into sustained adoption and measurable impact. People leadership — sets clear expectations, develops diverse talent, and creates a high-accountability, learning-oriented culture. Operational excellence — builds simple, reliable, documented, and scalable processes while maintaining strong controls. Communication and influence — explains complex issues clearly, challenges constructively, and enables timely decisions. Integrity and patient focus — applies sound judgment, respects compliance requirements, and keeps patient and customer value central to decisions. Requirements Required Bachelor's degree in business, life sciences, economics, statistics, data science, information systems, or a related discipline; an advanced degree is preferred. Typically 8+ years of relevant experience in commercial excellence, SFE, BI/CI, analytics, strategy, commercial operations, or related roles in pharmaceuticals, biotechnology, healthcare, or another highly regulated industry. Demonstrated leadership across multiple commercial effectiveness disciplines, with experience managing people, priorities, vendors, and senior stakeholders. Strong understanding of pharmaceutical commercial processes, including field operations, launch and brand planning, customer/account management, market research, forecasting, performance management, and data governance. Proven ability to synthesize complex quantitative and qualitative evidence into clear recommendations and influence decisions at leadership level. Experience working cross-functionally and across local, regional, and global teams in a matrix environment. Fluency in Japanese and business-level or higher English, with strong written, verbal, facilitation, and presentation skills in both languages. Demonstrated leade